Quantitative flow cytometric analysis of tumor-associated macrophages (TAMs) revealed no significant differences in either the absolute number of TAMs per tumor or their proportion among CD45+ cells between chimera-treated and control groups (Fig. 4c-d). Here, PTPRC is linked to neoplasm.